Stock Track | CareDx Soars 5.90% in Pre-Market as Wells Fargo Upgrades Rating

Stock Track
01-15

CareDx (CDNA) stock surged 5.90% in pre-market trading on Wednesday, fueled by an analyst rating upgrade from Wells Fargo.

The healthcare company's shares received a significant boost after Wells Fargo upgraded its rating on CDNA from "Underweight" to "Equal-Weight", signaling improved sentiment towards the stock. Despite lowering their price target from $28 to $24 per share, the new target still represents potential upside from current trading levels.

CareDx enjoys an average "overweight" rating from analysts covering the stock, according to data from FactSet. The mean price target among analysts stands at $32.25, further highlighting the positive outlook and growth prospects for the company.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10